Jaewoong Bae
Research Interests
Jaewoong Bae has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Hyunmi Kim
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
4 shared publications - Jihyun Kim
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea
4 shared publications - Kangmo Ahn
Department of Pediatrics, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul Republic of Korea
4 shared publications - Byung Eui Kim
Department of Pediatrics, National Jewish Health, Denver, CO, USA
3 shared publications - Jin-Seok Park
Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
3 shared publications - Seokjin Kim
R&D Center, Hecto Healthcare Co., Ltd, Seoul 06142, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 2 June 2026
- Published by Springer Nature in Research Square
Public B cell receptor clonotypes bridge chronic autoimmunity and lymphomagenesis
The genetic architecture of the antibody repertoires in chronic autoimmunity, and its relationship to B cell malignancy risk, remains incompletely defined. Using deep B cell receptor (BCR) heavy-chain sequencing from 20 Sjögren's syndrome (SS) patients (> 7 million unique sequences), compared to 11 age- and sex-matched healthy controls and 330 blood samples from 64 healthy donors, we identified 1,942 SS-associated extended stereotypic BCR clonotypes (eSBCs), alongside reductions in diversity and expansion of class-switched clonotypes. Nineteen eSBCs were shared by ≥ 4 of 20 patients (≥ 20%). The most prevalent clonotype (eSBC1; IGHV4-59/IGHJ2), detected in 65% of SS patients, matches in IGHV/IGHJ gene usage, and CDR3 features to a canonical rheumatoid factor (RF) previously reported in non-Hodgkin lymphoma and chronic lymphocytic leukemia, linking SS-associated autoreactive B cells to established lymphomagenic populations. RF activity was confirmed by ELISA for 10 BCRs spanning five SS-associated eSBCs with shared IGHV-CDR3 features, including eSBC1. Eight of the 19 eSBCs, including four RF-positive clonotypes, were also detected in rheumatoid arthritis and inflammatory demyelinating disease, revealing convergent autoantibody pathways across immune-mediated disorders. These results indicate that public clonotypes populate chronically autoreactive B cell pools across autoimmune diseases and B cell malignancies, supporting a model in which sustained autoantigen drive of public B cell clonotypes predisposes to lymphomagenesis.
- 2 June 2026
- Published by Springer Nature in Research Square
Open AccessPublic B cell receptor clonotypes bridge chronic autoimmunity and lymphomagenesis
The genetic architecture of the antibody repertoires in chronic autoimmunity, and its relationship to B cell malignancy risk, remains incompletely defined. Using deep B cell receptor (BCR) heavy-chain sequencing from 20 Sjögren's syndrome (SS) patients (> 7 million unique sequences), compared to 11 age- and sex-matched healthy controls and 330 blood samples from 64 healthy donors, we identified 1,942 SS-associated extended stereotypic BCR clonotypes (eSBCs), alongside reductions in diversity and expansion of class-switched clonotypes. Nineteen eSBCs were shared by ≥ 4 of 20 patients (≥ 20%). The most prevalent clonotype (eSBC1; IGHV4-59/IGHJ2), detected in 65% of SS patients, matches in IGHV/IGHJ gene usage, and CDR3 features to a canonical rheumatoid factor (RF) previously reported in non-Hodgkin lymphoma and chronic lymphocytic leukemia, linking SS-associated autoreactive B cells to established lymphomagenic populations. RF activity was confirmed by ELISA for 10 BCRs spanning five SS-associated eSBCs with shared IGHV-CDR3 features, including eSBC1. Eight of the 19 eSBCs, including four RF-positive clonotypes, were also detected in rheumatoid arthritis and inflammatory demyelinating disease, revealing convergent autoantibody pathways across immune-mediated disorders. These results indicate that public clonotypes populate chronically autoreactive B cell pools across autoimmune diseases and B cell malignancies, supporting a model in which sustained autoantigen drive of public B cell clonotypes predisposes to lymphomagenesis.
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (2) , 154-167
Postpartum Maternal Anxiety Affects the Development of Food Allergy Through Dietary and Gut Microbial Diversity During Early Infancy
Cho H, et al. Allergy Asthma Immunol Res. 2024 Mar;16(2):154-167. https://doi.org/10.4168/aair.2024.16.2.154
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (2) , 154-167
Open AccessPostpartum Maternal Anxiety Affects the Development of Food Allergy Through Dietary and Gut Microbial Diversity During Early Infancy
Cho H, et al. Allergy Asthma Immunol Res. 2024 Mar;16(2):154-167. https://doi.org/10.4168/aair.2024.16.2.154
- Open Access
- 3 March 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 777
Gut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment
Background: Ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) are used to treat patients with asymptomatic or mildly symptomatic gallstone disease. This study was conducted to evaluate the efficacy of gallbladder (GB) stone dissolution by UDCA/CDCA and the impact of treatment on gut microbial profiles. Methods: Fifteen treatment-naive patients with GB stones were initially included, but two dropped out during the treatment period. UDCA/CDCA was administered for 6 months. Abdominal ultrasonography was performed to evaluate response to treatment. In addition, fecal samples were collected before and after treatment for gut microbiome profiling. Then, 16S ribosomal RNA gene sequencing was carried out on fecal samples obtained before and after treatment, and results were compared with those of forty healthy controls. Results: Eight (62%) of the thirteen evaluable patients treated with UDCA/CDCA responded to treatment (four achieved complete GB stone resolution and four partial dissolution). Taxonomic compositions of fecal samples at the phylum level showed a significantly lower relative abundance of the Proteobacteria phylum in the pre-UDCA/CDCA group than in the healthy control group (p = 0.024). At the genus level, the relative abundances of five bacteria (Faecalibacterium, Roseburia, Lachnospira, Streptococcus, and Alistipes) differed in the control and pre-UDCA/CDCA group. Interestingly, the abundance of Roseburia was restored after 6 months of UDCA/CDCA treatment. Conclusion: Gut microbial dysbiosis was observed in GB stone patients and partially reversed by UDCA/CDCA treatment, which also effectively dissolved GB stones.
- 3 March 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 777
Open AccessGut Microbial Profile Changes in Patients with Gallbladder Stones after UDCA/CDCA Treatment
Background: Ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) are used to treat patients with asymptomatic or mildly symptomatic gallstone disease. This study was conducted to evaluate the efficacy of gallbladder (GB) stone dissolution by UDCA/CDCA and the impact of treatment on gut microbial profiles. Methods: Fifteen treatment-naive patients with GB stones were initially included, but two dropped out during the treatment period. UDCA/CDCA was administered for 6 months. Abdominal ultrasonography was performed to evaluate response to treatment. In addition, fecal samples were collected before and after treatment for gut microbiome profiling. Then, 16S ribosomal RNA gene sequencing was carried out on fecal samples obtained before and after treatment, and results were compared with those of forty healthy controls. Results: Eight (62%) of the thirteen evaluable patients treated with UDCA/CDCA responded to treatment (four achieved complete GB stone resolution and four partial dissolution). Taxonomic compositions of fecal samples at the phylum level showed a significantly lower relative abundance of the Proteobacteria phylum in the pre-UDCA/CDCA group than in the healthy control group (p = 0.024). At the genus level, the relative abundances of five bacteria (Faecalibacterium, Roseburia, Lachnospira, Streptococcus, and Alistipes) differed in the control and pre-UDCA/CDCA group. Interestingly, the abundance of Roseburia was restored after 6 months of UDCA/CDCA treatment. Conclusion: Gut microbial dysbiosis was observed in GB stone patients and partially reversed by UDCA/CDCA treatment, which also effectively dissolved GB stones.
- Open Access
Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction
Background: Staphylococcus (S) aureus colonization is known to cause skin barrier disruption in atopic dermatitis (AD) patients. However, it has not been studied how S. aureus induces aberrant epidermal lipid composition and skin barrier dysfunction.Methods: Skin tape strips (STS) and swabs were obtained from 24 children with AD (6.0 ± 4.4 years) and 16 healthy children (7.0 ± 4.5 years). Lipidomic analysis of STS samples was performed by mass spectrometry. Skin levels of methicillin‐sensitive and methicillin‐resistant S. aureus (MSSA and MRSA) were evaluated. The effects of MSSA and MRSA were evaluated in primary human keratinocytes (HEKs) and organotypic skin cultures.Results: AD and organotypic skin colonized with MRSA significantly increased the proportion of lipid species with nonhydroxy fatty acid sphingosine ceramide with palmitic acid ([N‐16:0 NS‐CER], sphingomyelins [16:0–18:0 SM]), and lysophosphatidylcholines [16:0–18:0 LPC], but significantly reduced the proportion of corresponding very long‐chain fatty acids (VLCFAs) species (C22–28) compared to the skin without S. aureus colonization. Significantly increased transepidermal water loss (TEWL) was found in MRSA‐colonized AD skin. S. aureus indirectly through interleukin (IL)‐1β, tumor necrosis factor (TNF)‐α, IL‐6, and IL‐33 inhibited expression of fatty acid elongase enzymes (ELOVL3 and ELOVL4) in HEKs. ELOVL inhibition was more pronounced by MRSA and resulted in TEWL increase in organotypic skin.Conclusion: Aberrant skin lipid profiles and barrier dysfunction are associated with S. aureus colonization in AD patients. These effects are attributed to the inhibition of ELOVLs by S. aureus‐induced IL‐1β, TNF‐α, IL‐6, and IL‐33 seen in keratinocyte models and are more prominent in MRSA than MSSA.
Open AccessStaphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction
Background: Staphylococcus (S) aureus colonization is known to cause skin barrier disruption in atopic dermatitis (AD) patients. However, it has not been studied how S. aureus induces aberrant epidermal lipid composition and skin barrier dysfunction.Methods: Skin tape strips (STS) and swabs were obtained from 24 children with AD (6.0 ± 4.4 years) and 16 healthy children (7.0 ± 4.5 years). Lipidomic analysis of STS samples was performed by mass spectrometry. Skin levels of methicillin‐sensitive and methicillin‐resistant S. aureus (MSSA and MRSA) were evaluated. The effects of MSSA and MRSA were evaluated in primary human keratinocytes (HEKs) and organotypic skin cultures.Results: AD and organotypic skin colonized with MRSA significantly increased the proportion of lipid species with nonhydroxy fatty acid sphingosine ceramide with palmitic acid ([N‐16:0 NS‐CER], sphingomyelins [16:0–18:0 SM]), and lysophosphatidylcholines [16:0–18:0 LPC], but significantly reduced the proportion of corresponding very long‐chain fatty acids (VLCFAs) species (C22–28) compared to the skin without S. aureus colonization. Significantly increased transepidermal water loss (TEWL) was found in MRSA‐colonized AD skin. S. aureus indirectly through interleukin (IL)‐1β, tumor necrosis factor (TNF)‐α, IL‐6, and IL‐33 inhibited expression of fatty acid elongase enzymes (ELOVL3 and ELOVL4) in HEKs. ELOVL inhibition was more pronounced by MRSA and resulted in TEWL increase in organotypic skin.Conclusion: Aberrant skin lipid profiles and barrier dysfunction are associated with S. aureus colonization in AD patients. These effects are attributed to the inhibition of ELOVLs by S. aureus‐induced IL‐1β, TNF‐α, IL‐6, and IL‐33 seen in keratinocyte models and are more prominent in MRSA than MSSA.
- Open Access
- 1 January 2023
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 15 (2) , 186-200
Alterations of Epidermal Lipid Profiles and Skin Microbiome in Children With Atopic Dermatitis
Kim J, et al. Allergy Asthma Immunol Res. 2023 Mar;15(2):186-200. https://doi.org/10.4168/aair.2023.15.2.186
- 1 January 2023
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 15 (2) , 186-200
Open AccessAlterations of Epidermal Lipid Profiles and Skin Microbiome in Children With Atopic Dermatitis
Kim J, et al. Allergy Asthma Immunol Res. 2023 Mar;15(2):186-200. https://doi.org/10.4168/aair.2023.15.2.186
- Open Access
Bile Microbiome in Patients with Recurrent Common Bile Duct Stones and Correlation with the Duodenal Microbiome
Background: Common bile duct (CBD) stone recurrence is a common late adverse event after CBD stone treatment. In this preliminary study, we compared the bile fluid and duodenum microbial profiles of patients with or without recurrent CBD stones to identify risk factors associated with recurrence. Methods: Bile fluid samples of 47 consecutive patients who underwent ERCP for biliary diseases were subjected to microbiome analysis. Nineteen patients were stone-recurrent (SR), and 28 patients were non-stone-recurrent (NSR). Paired samples (duodenum biopsy tissue and bile fluid samples) from five SR patients were used to compare microbiome compositions in the biliary system and duodenum. In addition, we compared the microbiome compositions of these duodenal tissue samples with those 12 controls (gastric ulcer patients without recurrent CBD stones). Results: Enterococcaceae_unclassified and enterococcus were more abundant in bile fluid in the SR group than in the NSR group (p = 0.002 and p = 0.003, respectively). A comparison of the microbiome compositions of duodenum tissue and bile fluid samples of the five recurrent CBD stone patients revealed proteobacteria compositions were almost identical from the phylum to genus level. In these five patients, alpha and beta diversities were no different in bile fluid and duodenal tissues. Furthermore, a comparison of the microbiome compositions of duodenal mucosa in patients with recurrent CBD stone patients (n = 5) and controls (n = 12) revealed significant differences between microbiome compositions. Conclusions: Enterococcus seems to contribute to CBD stone development. Furthermore, our results indicate that retrograde migration of the duodenal microbiome may contribute to bile microbiome alterations. We recommend that more research be conducted to confirm this hypothesis.
Open AccessBile Microbiome in Patients with Recurrent Common Bile Duct Stones and Correlation with the Duodenal Microbiome
Background: Common bile duct (CBD) stone recurrence is a common late adverse event after CBD stone treatment. In this preliminary study, we compared the bile fluid and duodenum microbial profiles of patients with or without recurrent CBD stones to identify risk factors associated with recurrence. Methods: Bile fluid samples of 47 consecutive patients who underwent ERCP for biliary diseases were subjected to microbiome analysis. Nineteen patients were stone-recurrent (SR), and 28 patients were non-stone-recurrent (NSR). Paired samples (duodenum biopsy tissue and bile fluid samples) from five SR patients were used to compare microbiome compositions in the biliary system and duodenum. In addition, we compared the microbiome compositions of these duodenal tissue samples with those 12 controls (gastric ulcer patients without recurrent CBD stones). Results: Enterococcaceae_unclassified and enterococcus were more abundant in bile fluid in the SR group than in the NSR group (p = 0.002 and p = 0.003, respectively). A comparison of the microbiome compositions of duodenum tissue and bile fluid samples of the five recurrent CBD stone patients revealed proteobacteria compositions were almost identical from the phylum to genus level. In these five patients, alpha and beta diversities were no different in bile fluid and duodenal tissues. Furthermore, a comparison of the microbiome compositions of duodenal mucosa in patients with recurrent CBD stone patients (n = 5) and controls (n = 12) revealed significant differences between microbiome compositions. Conclusions: Enterococcus seems to contribute to CBD stone development. Furthermore, our results indicate that retrograde migration of the duodenal microbiome may contribute to bile microbiome alterations. We recommend that more research be conducted to confirm this hypothesis.
- Open Access
- 31 March 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (4) , 470
Changes to Gut Microbiota Following Systemic Antibiotic Administration in Infants
Long-term antibiotic use can have consequences on systemic diseases, such as obesity, allergy, and depression, implicating the causal role of gut microbiome imbalance. However, the evaluation of the effect of antibiotics in early infancy on alterations to the gut microbiome remains poorly understood. This study aimed to evaluate the gut microbiome state in infancy following systemic antibiotic treatment. Twenty infants under 3 months of age who had received antibiotics for at least 3 days were enrolled, and their fecal samples were collected 4 weeks after antibiotic administration finished. Thirty-four age-matched healthy controls without prior exposure to antibiotics were also assessed. The relative bacterial abundance in feces was obtained via sequencing of 16 S rRNA genes, and alpha and beta diversities were evaluated. At the genus level, the relative abundance of Escherichia/Shigella and Bifidobacterium increased (p = 0.03 and p = 0.017, respectively) but that of Bacteroides decreased (p = 0.02) in the antibiotic treatment group. The microbiome of the antibiotic treatment group exhibited an alpha diversity lower than that of the control group. Thus, systemic antibiotic administration in early infancy affects the gut microbiome composition even after a month has passed; long-term studies are needed to further evaluate this.
- 31 March 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (4) , 470
Open AccessChanges to Gut Microbiota Following Systemic Antibiotic Administration in Infants
Long-term antibiotic use can have consequences on systemic diseases, such as obesity, allergy, and depression, implicating the causal role of gut microbiome imbalance. However, the evaluation of the effect of antibiotics in early infancy on alterations to the gut microbiome remains poorly understood. This study aimed to evaluate the gut microbiome state in infancy following systemic antibiotic treatment. Twenty infants under 3 months of age who had received antibiotics for at least 3 days were enrolled, and their fecal samples were collected 4 weeks after antibiotic administration finished. Thirty-four age-matched healthy controls without prior exposure to antibiotics were also assessed. The relative bacterial abundance in feces was obtained via sequencing of 16 S rRNA genes, and alpha and beta diversities were evaluated. At the genus level, the relative abundance of Escherichia/Shigella and Bifidobacterium increased (p = 0.03 and p = 0.017, respectively) but that of Bacteroides decreased (p = 0.02) in the antibiotic treatment group. The microbiome of the antibiotic treatment group exhibited an alpha diversity lower than that of the control group. Thus, systemic antibiotic administration in early infancy affects the gut microbiome composition even after a month has passed; long-term studies are needed to further evaluate this.
- Open Access
- 1 January 2022
- Published by XMLink in Immune Network
- Vol. 22 (2) , e17
Dietary Diversity during Early Infancy Increases Microbial Diversity and Prevents Egg Allergy in High-Risk Infants
Lee BR, et al. Immune Netw. 2021 Nov;22(2):e17. https://doi.org/10.4110/in.2022.22.e17
- 1 January 2022
- Published by XMLink in Immune Network
- Vol. 22 (2) , e17
Open AccessDietary Diversity during Early Infancy Increases Microbial Diversity and Prevents Egg Allergy in High-Risk Infants
Lee BR, et al. Immune Netw. 2021 Nov;22(2):e17. https://doi.org/10.4110/in.2022.22.e17
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (15) , e94
Bile Microbiota in Patients with Pigment Common Bile Duct Stones
Kim B, et al. J Korean Med Sci. 2021 Mar;36(15):e94. https://doi.org/10.3346/jkms.2021.36.e94
- 1 January 2021
- Published by XMLink in Journal of Korean Medical Science
- Vol. 36 (15) , e94
Open AccessBile Microbiota in Patients with Pigment Common Bile Duct Stones
Kim B, et al. J Korean Med Sci. 2021 Mar;36(15):e94. https://doi.org/10.3346/jkms.2021.36.e94